What Happened: Costco’s new weight loss initiative, in partnership with Sesame, a healthcare marketplace, will offer members a three-month clinical consultation and other services for $179, reported Fox Business.
The program will allow clinicians to prescribe medications such as Novo Nordisk’s Ozempic and Wegovy, and Eli Lilly’s Mounjaro and Zepbound, which have gained popularity for their weight loss benefits.
Sesame CEO David Goldhill said, “We are witnessing important innovations in medically-supervised weight loss. Sesame's unique model allows us not only to make high-quality specialty care like weight loss much more accessible and affordable, but also to empower clinicians to create care plans that are specific to — and appropriate for — each individual patient.”
This expanded partnership follows an earlier collaboration between Costco and Sesame, which provided Costco members with discounted core healthcare services. The new program is available to members across all 50 states.
Meanwhile, Novo Nordisk has been under scrutiny for the high prices of its diabetes drug, Ozempic, with Sen. Bernie Sanders (I-Vt.) considering hearings on the issue and seeking a meeting with the company's CEO to discuss reducing the drug's price.
Costco’s new program, offering access to these popular weight loss medications, is a significant addition to the evolving weight loss market. It provides its members with more accessible and affordable options for their weight management journey.
Image Via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
